Seres Therapeutics, Inc.
MCRB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $136 | -$113,724 | -$250,157 | -$65,578 |
| Dep. & Amort. | $5,468 | $6,243 | $6,629 | $5,947 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $20,971 | $34,101 | $25,482 | $20,222 |
| Change in WC | -$65,509 | -$58,977 | -$18,391 | $41,530 |
| Other Non-Cash | -$109,675 | $15,003 | $7,621 | $4,567 |
| Operating Cash Flow | -$148,609 | -$117,354 | -$228,816 | $6,688 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$380 | -$7,975 | -$9,821 | -$9,566 |
| Net Acquisitions | $0 | $0 | -$92,249 | $0 |
| Inv. Purchases | $13,516 | -$4,426 | -$48,221 | -$95,971 |
| Inv. Sales/Matur. | $142,673 | $22,983 | $140,470 | $169,625 |
| Other Inv. Act. | -$13,516 | $0 | $92,249 | $0 |
| Investing Cash Flow | $142,293 | $10,582 | $82,428 | $64,088 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$127,905 | $50,518 | $25,699 | -$948 |
| Stock Issued | $23,530 | $18,159 | $101,168 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $14,003 | $3,028 | $2,735 | $2,126 |
| Financing Cash Flow | -$90,372 | $71,705 | $129,602 | $1,178 |
| Forex Effect | -$1 | $2 | -$1 | -$1 |
| Net Chg. in Cash | -$96,689 | -$35,065 | -$16,787 | $71,953 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $136,150 | $171,215 | $188,002 | $116,049 |
| End Cash | $39,461 | $136,150 | $171,215 | $188,002 |
| Free Cash Flow | -$148,989 | -$125,329 | -$238,637 | -$2,878 |